science
Hosted by Crown Bioscience · science · EN-US
CrownCast, Crown Bioscience's podcast aims to discuss the emerging trends,breakthroughs, and viewpoints in oncology drug discovery, and development.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
29%
Guest openness
Selective
Sign up to generate a grounded pitch for CrownCast.
Signup to Generate a PitchCrownCast is hosted by Crown Bioscience. The show has published 14 episodes to date.
Recent episodes include "Syngeneic vs. Humanized Models: How to Choose the Right Model for Immuno-Oncology Research" (23 September 2026, 10 minutes), "Top Cancer Research Trends and Innovations Identified by Experts" (29 May 2026, 13 minutes), and "Mastering Radiopharmaceutical Development - Preclinical Model Selection for Clinical Success" (26 March 2026, 34 minutes).
CrownCast publishes roughly every few months, with episodes averaging 25 minutes across 14 episodes.
Booking probability for CrownCast is 29%, and the host is rated Selective on guests. CrownCast requires a Pod Score of 80 or higher. CrownCast's contact route on record: verified email.
The strongest fits for CrownCast are Scientific Research & Development and Pharmaceuticals. CrownCast has a science audience.
Crown Bioscience hosts CrownCast, a science podcast with 14 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #1
Choosing the right preclinical immuno-oncology model makes or breaks your development decisions, but navigating the options is rarely simple. In this CrownCast episode, host Michelle Dawn Mooney sits down with Chris...
At AACR 2026, one message became clear: oncology drug development is entering a new era defined by smarter decision-making, integrated platforms, and increasingly precise therapeutic strategies. In this CrownCast...
Episode #1
<p>What if the next breakthrough in cancer treatment isn't a pill or infusion, but a precisely targeted radioactive payload that hunts down tumor cells like a guided missile? In this Smart Biotech Scientist Podcast...
<p>When people hear Crown Bioscience, they often think of world-class in vivo oncology models - and for good reason. But behind every successful oncology program is something just as critical: understanding how a drug...
CrownCast
<p>Across the global oncology drug discovery landscape, the UK stands at the forefront. In this CrownCast episode, Rajendra Kumari, Executive Director of Integrated Solutions at Crown Bioscience, talks with Sarah...
<p>As cancer research progresses rapidly, obtaining high-quality biospecimens has grown increasingly important for making significant breakthroughs.</p> <p>In this CrownCast episode, Rajendra Kumari, Executive Director...
<p>As the landscape of drug discovery evolves, breakthrough technologies like organoids are gaining traction for their potential to revolutionize how new treatments are developed. In this episode of CrownCast, Jonny...
What if the biggest barrier to faster, safer drug development isn't a lack of technology, but a decades-old reliance on the wrong models? In this episode of CrownCast, host Michelle Dawn Mooney sits down with Prof...
Episode #1
Oncology continues to be a rapidly changing field with scientific discoveries transforming patient treatment and care. As it stands today, advancements in biomarkers are playing a vital role in furthering drug...
In the dynamic field of oncology research, KRAS has long been a formidable opponent. Originally deemed undruggable, recent breakthroughs have now positioned KRAS as a beacon of hope for developing targeted cancer...
<p>In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment...
<p>Artificial intelligence is rapidly reshaping the drug discovery process, moving from augmenting research to actively driving innovation. As biotech companies face soaring R&D costs and long development cycles, AI...
<p>In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in...
<p>Are you ready to understand the seismic shifts in the CRO (Contract Research Organization) industry? Join Johnny McMichael, VP of Client Experience and Enablement at Crown Bioscience, and Alex Slater, Chief Business...
Recent guests on CrownCast. Study who booked and why before you pitch.
Executive Director of In Vivo, North Carolina Court of Appeals
Director of Scientific and Technical Operations, Southeastern Indiana REMC
Senior Director of Business Development, WIU Training and Consultation (TaC) Team
Professor for Pharmacology and Toxicology, Johns Hopkins Center for Alternatives to Animal Testing
PitchCentric classifies CrownCast under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ
